Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy. | Bioact Mater | 2024 | 37637082 | PubTator, text mining | PubMed |
| Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2024 | 37634036 | PubTator, text mining | PubMed |
| Clinical Biofluid Assays for Prostate Cancer. | Cancers (Basel) | 2023 | 38201592 | PubTator, text mining | PubMed |
| Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers. | Res Sq | 2023 | 38168280 | PubTator, text mining | PubMed |
| Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration. | Animals (Basel) | 2023 | 38136890 | PubTator, text mining | PubMed |
| A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy. | Biomolecules | 2023 | 38136558 | PubTator, text mining | PubMed |
| Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma. | Curr Issues Mol Biol | 2023 | 38132440 | PubTator, text mining | PubMed |
| Drug-drug interaction prediction: databases, web servers and computational models. | Brief Bioinform | 2023 | 38113076 | PubTator, text mining | PubMed |
| Symphony in the crowd: Key genetic alterations in prostate cancer. | Cancer Innov | 2023 | 38089408 | PubTator, text mining | PubMed |
| Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. | iScience | 2023 | 38077153 | PubTator, text mining | PubMed |
| A new approach to prostate cancer screening. | Adv Lab Med | 2023 | 38075179 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. | Cancers (Basel) | 2023 | 38067373 | PubTator, text mining | PubMed |
| Rational optimization of a transcription factor activation domain inhibitor. | Nat Struct Mol Biol | 2023 | 38049566 | PubTator, text mining | PubMed |
| Partial validation of multiplexed real-time quantitative PCR assays for forensic body fluid identification. | Sci Justice | 2023 | 38030341 | PubTator, text mining | PubMed |
| Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer. | Comput Struct Biotechnol J | 2023 | 38022698 | PubTator, text mining | PubMed |
| A small molecule exerts selective antiviral activity by targeting the human cytomegalovirus nuclear egress complex. | PLoS Pathog | 2023 | 37976321 | PubTator, text mining | PubMed |
| Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer. | J Clin Invest | 2023 | 37966114 | PubTator, text mining | PubMed |
| Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. | Arch Esp Urol | 2023 | 37960958 | PubTator, text mining | PubMed |
| Biomarkers for Prostate Cancer: From Diagnosis to Treatment. | Diagnostics (Basel) | 2023 | 37958246 | PubTator, text mining | PubMed |
| The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study. | Sci Rep | 2023 | 37919464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=4